Psoriasis Treatments: Emerging Roles and Future Prospects of MicroRNAs

Li Tian Keane Teo1, Nerissa Juantuah-Kusi2,3, Gowtham Subramanian3,4

  • 1Department of Life Sciences, Imperial College London, Sir Ernst Chain Building, South Kensington, London SW7 2AZ, UK.

Non-Coding RNA
|February 25, 2025
PubMed

Insights

Psoriasis is a chronic skin disease with no cure. MicroRNAs (miRNAs) are key regulators in its development and offer promising therapeutic potential for future treatments.

Area of Science:

  • Dermatology and Molecular Biology
  • Investigating the molecular mechanisms of skin diseases

Background:

  • Psoriasis is a chronic, inflammatory skin condition with complex pathogenesis.
  • Genetic, immunological, and environmental factors contribute to psoriasis development.
  • MicroRNAs (miRNAs) are increasingly recognized for their role in hyperproliferative skin disorders.

Purpose of the Study:

  • To review the emerging significance of miRNAs in psoriasis pathogenesis.
  • To examine the potential of miRNAs as therapeutic targets for psoriasis.

Main Methods:

  • This study is a narrative review of current research on miRNAs and psoriasis.
  • Literature search on microRNA regulation in hyperproliferative skin diseases.
  • Analysis of current psoriasis treatments and future therapeutic strategies.

Main Results:

  • MicroRNAs play a pivotal role in regulating key processes in psoriasis.
  • Dysregulation of specific miRNAs is implicated in psoriasis pathogenesis.
  • miRNAs represent a promising area for novel therapeutic interventions.

Conclusions:

  • MicroRNAs are significant regulators in the complex pathogenesis of psoriasis.
  • Targeting miRNAs offers a potential avenue for next-generation psoriasis therapies.
  • Further research into miRNA-based treatments could revolutionize psoriasis management.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
796